Loading the state's markets…
Loading the state's markets…
Loading the market…
Medicare market size, surgeons and outlook to 2030
Medicare fee-for-service cochlear implants cases in California: reported (2020, the pandemic year, left out of the line), then forecast with its 80% range. One year ahead, this procedure’s market forecast has been off by 23% on average (17 state-years, 2020–2024): small markets swing, so treat it as rough.
| Year | Surgeons | Medicare FFS | Advantage share |
|---|---|---|---|
| 2019 | 9 | 257 | 48% |
| 2020 | 6 | 215 | 50% |
| 2021 | 6 | 271 | 52% |
| 2022 | 8 | 312 | 53% |
| 2023 | 13 | 363 | 55% |
| 2024 | 14 | 436 | 56% |
| 2025 from claims | – | 480 388–563 | 56% |
| 2026 forecast | – | 529 414–664 | 56% |
| 2027 forecast | – | 580 430–767 | 56% |
| 2028 forecast | – | 636 450–878 | 56% |
| 2029 forecast | – | 698 474–1,000 | 57% |
| 2030 forecast | – | 765 501–1,136 | 57% |
Cochlear implantation, children and adults. Professional codes (what the surgeon bills): CPT 69930.
Surgeons and fee-for-service cases are from CMS’s Medicare Physician & Other Practitioners files, counted where the surgeon billed; state totals include the cases CMS leaves out of the surgeon-level file (under 11 patients). All Medicare adds patients in Medicare Advantage at the state’s enrollment share; all payers scales Medicare by its share of the procedure nationally. The forecast carries cases per resident 65+ forward with the Census projection of residents 65+. How the numbers are made · Data sources
The 10 busiest do 79% of the cases CMS names in California; 11 surgeons do 80% of them.
MedaRep names every one, ranked by volume, with their practice, hospitals, trend, forecast and which device companies already engage with them.
In 2025, 72% hospital outpatient, 28% surgery center. The share outside the hospital has moved +7 pts since 2019, so more of this market is decided in surgery centers and offices each year.
| Forecast, Medicare FFS | Hospital outpatient | Surgery center |
|---|---|---|
| 2026 · ~530 | ~380 | ~150 |
| 2027 · ~580 | ~410 | ~170 |
| 2028 · ~640 | ~450 | ~180 |
The forecast’s cases at the projected mix.
If the trend since 2022 holds, slowing as it goes, by 2028: surgery center about 29% (28% in 2025), hospital outpatient about 71% (72% in 2025). More of these cases each year are decided in surgery centers, where the surgeons often own the center and weigh price and turnaround.
| State | Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast |
|---|---|---|---|---|---|---|
| Arizona | 8 | 188+10%/yr | +10%/yr | 0.3 | 0% | 200 in 2030+1%/yr |
| Colorado | 4 | 157+3.7%/yr | +3.7%/yr | 0.3 | 0% | 110 in 2030−5.3%/yr |
| Washington | 3 | 144+3.9%/yr | +3.9%/yr | 0.2 | 33% | 320 in 2030+14%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Sinus surgery & balloon dilation | 131 | 15,296−0.9%/yr | −0.9%/yr | 4.61.0× | 88% | 19,700 in 2030+4.3%/yr |
| Ear tubes & middle ear surgery | 3 | 633−0.6%/yr | −0.6%/yr | 0.20.8× | 58% | 510 in 2030−3.5%/yr |
| Sleep apnea & airway implants | 8 | 343+39%/yr | +39%/yr | 0.10.5× | 11% | 410 in 2030+3.1%/yr |
Cochlear implants in every state, and its device makers · Every procedure market in California · Every state · Compare with Arizona
Cochlear leads with 54% of company spending on these surgeons in 2025, +22 pts on 2024.
In 2025, 7 companies reported engagement with California’s surgeons worth $109K in consulting, speaking, meals and travel tied to these products, about $7,786 per surgeon billing it. Royalties are left out.
FDA, last 12 months: 15 clearances and approvals in the category, 3 recalled product lines. A recall is a public FDA notice, not a finding of fault.
Which surgeons each company engages, and the dollars reported, are in the ranking. Open Payments shows the payments companies reported. It suggests engagement, not which devices a surgeon uses, and is not evidence of wrongdoing. Every company in the category.
Share of the cases CMS names by surgeon, by where they billed. Open one for its ranking.